▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / BXBL

BXBL — BOXABL Inc.

—
Nasdaq · Financials · Diversified Financial Services · CIK 1906364 ·
Last close
$3.94
Market Cap
—
52W High
$15.14
52W Low
$3.80
ADV30
496,955
Next earnings
—
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,556,000 -3,353,000 -7,633,000 -7,579,000 61,658,000 22,256,000 14,920,000
Dec 2025 926,000 -2,613,000 -6,006,000 -5,704,000 69,259,000 29,022,000 15,242,000
Sep 2025 186,000 -1,748,000 -11,259,000 -10,782,000 77,725,000 34,503,000 17,872,000
Jun 2025 279,000 -9,444,000 -31,200,000 -30,800,000 81,262,000 14,776,000 18,128,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-39,488,000
Investing CF
$6,072,000
Financing CF
$44,366,000
CapEx
$-262,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.17
As of
2026-07-26

Balance + Analyst (yfinance extras)

Retained Earnings
$-783,563,000
Inventory
$18,177,000
Receivables
$1,332,000
ST Investments
$0
EBIT TTM
$-56,098,000
Pretax Income TTM
$-54,865,000
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,514,000 -59,200,000 -57,549,000 69,259,000 15,242,000 — -47,175,000
Dec 2024 3,376,000 -40,290,000 -50,950,000 75,047,000 19,612,000 — -38,400,000
Dec 2023 344,000 -41,760,000 -39,526,000 107,525,000 25,178,000 — -35,622,000
Dec 2022 10,867,746 -33,091,215 -610,748,564 110,082,401 12,262,715 — -33,276,399

Peers — same industry

TickerNameMarket CapLastDaily %
HASI HA Sustainable Infrastructure Capital, Inc. $4.91B $38.42 —
DMII Drugs Made In America Acquisition II Corp. $643.69M $10.10 —
EVAC EQV Ventures Acquisition Corp. II $480.28M $10.23 —
BCSS Bain Capital GSS Investment Corp. $479.83M $10.23 —
CEPF Cantor Equity Partners IV, Inc. $479.20M $10.44 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →